Enlivex Ltd.
ENLV- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001596812
No open-market purchases or sales by Enlivex Ltd. insiders were filed in the last 90 days; 25 institutions reported holding it in 13F filings for Q2 2026, worth $2.34M in total; ARK Invest is the only superinvestor holding it.
13F holders, Q2 2022
Institutional positions in Enlivex Ltd. as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 22
- −3 vs. Q1 2022
- Shares held
- 604.7K
- −241.6K (−28.5%) vs. Q1 2022
- Total value
- $2.89M
- −$1.86M (−39.2%) vs. Q1 2022
- New holders
- 3
- 4 more added
- Sold out
- 6
- 6 more reduced
Compare with Q1 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ENLV on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 25 | $2.34M |
| Q1 2026 | 35 | $3.38M |
| Q4 2025 | 25 | $929.4K |
| Q3 2025 | 29 | $950.2K |
| Q2 2025 | 21 | $2.87M |
| Q1 2025 | 26 | $3.08M |
| Q4 2024 | 24 | $3.99M |
| Q3 2024 | 19 | $4.31M |
| Q2 2024 | 17 | $2.96M |
| Q1 2024 | 15 | $1.24M |
| Q4 2023 | 17 | $509.2K |
| Q3 2023 | 16 | $408.4K |
| Q2 2023 | 19 | $795.1K |
| Q1 2023 | 19 | $1.24M |
| Q4 2022 | 21 | $1.32M |
| Q3 2022 | 18 | $1.41M |
| Q2 2022 | 22 | $2.89M |
| Q1 2022 | 25 | $4.75M |
| Q4 2021 | 23 | $4.12M |
| Q3 2021 | 20 | $8.38M |
| Q2 2021 | 20 | $8.79M |
| Q1 2021 | 23 | $11.7M |
Institutions, Q2 2022
Shares, value and share of portfolio for each institution holding Enlivex Ltd.; share changes are against Q1 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| ARK Investment Management LLCSuperinvestorARK Invest | 331,001 | $1.66M | 0.01% | −103,342−23.8% | Reduced |
| Renaissance Technologies LLC | 64,189 | $290.0K | 0.00% | +500+0.8% | Added |
| Compagnie Lombard Odier SCmA | 50,000 | $223.0K | 0.01% | 00.0% | Unchanged |
| Morgan Stanley | 32,725 | $148.0K | 0.00% | +11,150+51.7% | Added |
| State Street Corp | 21,887 | $99.0K | 0.00% | +451+2.1% | Added |
| Susquehanna International Group Ltd. | 22,002 | $98.0K | 0.02% | −470−2.1% | Reduced |
| UBS Group AG | 18,381 | $83.0K | 0.00% | +698+3.9% | Added |
| ACT Capital Management, LLC | 15,000 | $68.0K | 0.10% | −10,000−40.0% | Reduced |
| Edmond de Rothschild Holding S.A. | 13,000 | $59.0K | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 12,373 | $56.0K | 0.00% | −3,241−20.8% | Reduced |
| Geode Capital Management, LLC | 10,420 | $47.0K | 0.00% | 00.0% | Unchanged |
| Simplex Trading, LLC | 4,305 | $19.0K | 0.00% | +4,305 | New |
| Steward Partners Investment Advisory, LLC | 3,000 | $14.0K | 0.00% | 00.0% | Unchanged |
| Group One Trading, L.P. | 2,884 | $13.0K | 0.00% | −19,685−87.2% | Reduced |
| Bank of America Corp | 1,215 | $5.00K | 0.00% | −4,948−80.3% | Reduced |
| Barclays PLC | 1,000 | $5.00K | 0.00% | 00.0% | Unchanged |
| Umb Bank N A | 550 | $2.00K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 400 | $2.00K | 0.00% | 00.0% | Unchanged |
| ACG Wealth | 200 | $1.00K | 0.00% | +200 | New |
| SRS Capital Advisors, Inc. | 140 | $1.00K | 0.00% | +140 | New |
| Captrust Financial Advisors | 25 | $0 | 0.00% | 00.0% | Unchanged |
| Ahrens Investment Partners LLC | 50 | $0 | 0.00% | 00.0% | Unchanged |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −52,507−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −36,560−100.0% | Sold out |
| Belvedere Trading LLC | 0 | $0 | 0.00% | −14,473−100.0% | Sold out |
| Goldman Sachs Group Inc | 0 | $0 | 0.00% | −12,205−100.0% | Sold out |
| JPMorgan Chase & Co | 0 | $0 | 0.00% | −1,152−100.0% | Sold out |
| Harel Insurance Investments & Financial Services Ltd. | 0 | $0 | 0.00% | −460−100.0% | Sold out |